[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369912-105":59,"doc-detail-369912-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","an-in-vitro-tumor-recurrence-model-based-on-platinum-resistant-colon-cancer-cells-as-a-research-tool-for-studying-cancer-cell-dormancy","An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy","","Modeling cancer recurrence and associated conditions such as cancer cell dormancy remains a significant challenge in cancer research. An in vitro system was developed using platinum-resistant tumor cells exposed to a platinum drug, where cells progress through recurrence stages within 30–40 days post-exposure. Platinum-resistant colorectal cancer cells treated with oxaliplatin show enrichment of quiescent G0/G1-arrested dormant cells, with increased autophagy, elevated stem cell marker expression, reduced ROS, and stronger chemotherapy resistance, supported by high residual-cell survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-in-vitro-tumor-recurrence-model-based-on-platinum-resistant-colon-cancer-cells-as-a-research-tool-for-studying-cancer-cell-dormancy/369912/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-in-vitro-tumor-recurrence-model-based-on-platinum-resistant-colon-cancer-cells-as-a-research-tool-for-studying-cancer-cell-dormancy/369912.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What research problem does the study address?","Question",{"text":112,"@type":113},"Cancer recurrence and related cancer cell dormancy are difficult to model and study using existing approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is the in vitro tumor recurrence model constructed?",{"text":117,"@type":113},"Platinum-resistant tumor cells are treated with a platinum drug so that the cell population progresses through recurrence stages within 30–40 days after exposure.",{"name":119,"@type":110,"acceptedAnswer":120},"What cellular characteristics do the treated dormant cells show?",{"text":121,"@type":113},"The model enriches for quiescent dormant cells arrested in G0/G1, with increased autophagy, higher stem cell marker expression, lower ROS levels, and enhanced resistance to chemotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369912,1790292678,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","OPEN ACCESS  \nCitation: Morshneva A, Gnedina O, Igotti M (2025) An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy. PLoS One 20(10): e0333671 .  \n[https://doi.org/10.1371/journal.pone.0333671](https://doi.org/10.1371/journal.pone.0333671)[ ](https://doi.org/10.1371/journal.pone.0333671)Editor: Li Yang, Sichuan University, CHINA  \nReceived: April 16, 2025  \nAccepted: September 17, 2025  \nPublished: October 8, 2025  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0333671  \nCopyright: © 2025 Morshneva et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nRESEARCH ARTICLE  \nAn in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy  \nAlisa Morshneva*, Olga Gnedina, Maria Igotti  \nInstitute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia  \n* [amorshneva@incras.ru](amorshneva@incras.ru)  \nAbstract  \nModeling cancer recurrence and associated conditions such as cancer cell dormancy remains a significant challenge in cancer research. We developed a novel in vitro model based on platinum-resistant tumor cells treated with a platinum drug, in which cells progress through all stages of recurrence within 30–40 days post-exposure. Our results demonstrate that treatment of platinum-resistant colorectal cancer cells with oxaliplatin enriches the population with quiescent, dormant cells arrested in the G0/ G1 phase. These cells exhibit increased autophagy, elevated expression of stem cell markers, reduced reactive oxygen species (ROS) levels, and heightened resistance to chemotherapy. A key advantage of our model is the high survival rate of residual cells, enabling the maintenance of a large cell population. This facilitates the application of conventional research techniques that are often limited in other recurrence models due to the small size of residual populations. Overall, this model provides opportunities for a wide range of further research for studying specific recurrenceand dormancy-associated signaling pathways and for identifying novel therapeutic targets for preventing tumor recurrence.  \nIntroduction  \nTumor recurrence remains one of the most pressing challenges complicating cancer treatment. The major cause of late recurrence is the reactivation of residual cancer cells, leading to a new burst of tumor growth that is more difficult to suppress. These residual cancer cells constitute a heterogeneous population, including drug-resistant, dormant, stem and other cell types that survive after cancer treatment [ 1] . To date, cancer cell dormancy is considered one of the key steps in the development of tumor recurrence [2] .  \nCancer cell dormancy is a state in which cancer cells reversibly stop proliferation and enter a quiescent phase [3] . These cells remain viable but do not proliferate, which makes them particularly difficult to detect and treat using traditional  \nPLOS One | [https://doi.org/10.1371/journal.pone.0333671](https://doi.org/10.1371/journal.pone.0333671) October 8, 2025 1 / 21  \nData availability statement: All relevant data are within the manuscript and its Supporting  Information files.  \nFunding: This study was supported by the Russian Science Foundation (project No. 24-25- 20164, [https://rscf.ru/project/24-25-20164/](https://rscf.ru/project/24-25-20164/)) and the St. Petersburg Science Foundation (Russia) . The funders had no role in study desig","cbCaiaJ5YbQjE30H","https://ap.wps.com/l/cbCaiaJ5YbQjE30H","pdf",2497650,21,"English","# Abstract\n# Introduction\n## Cancer recurrence and residual drug-resistant cells\n## Cancer cell dormancy as a reversible quiescent state\n## Need for new in vitro research models\n## In vitro modeling links to metastasis, MRD, recurrence, and dormancy\n## 2D/3D culture systems and inducing cellular quiescence\n# Objective and approach","[{\"question\":\"What research problem does the study address?\",\"answer\":\"Cancer recurrence and related cancer cell dormancy are difficult to model and study using existing approaches.\"},{\"question\":\"How is the in vitro tumor recurrence model constructed?\",\"answer\":\"Platinum-resistant tumor cells are treated with a platinum drug so that the cell population progresses through recurrence stages within 30–40 days after exposure.\"},{\"question\":\"What cellular characteristics do the treated dormant cells show?\",\"answer\":\"The model enriches for quiescent dormant cells arrested in G0/G1, with increased autophagy, higher stem cell marker expression, lower ROS levels, and enhanced resistance to chemotherapy.\"}]","An in vitro tumor recurrence model based on platinum-resistant colon cancer cells as a research tool for studying cancer cell dormancy | PDF",1790185189,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1db4162d5b235233e549bab716832be6.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58f14f1128998aa8025176ec864608a9.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e28b56d408c3645c022ae8ce404c004.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd701504fffebd9ef40315504406ec09.webp",980,1268]